PLAU and ovarian cancer: Similarly, exosomes of ovarian cancer ascites contain MMP-2, MMP-9 and urokinase-type plasminogen activator (uPa), all of them able to degrade the ECM, facilitating invasion and dissemination of tumor cells [53].